Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2005
08/02/2005US6923964 amyloid fibrils; for preventing/treating amyloid diseases/Alzheimer's disease
08/02/2005US6923959 Method of pre-inducing a state of immune tolerance before organ transplantation
08/02/2005US6923951 Non-invasive localization of a light-emitting conjugate in a mammal
08/02/2005US6923950 hexokinase ligands for diagnosis of cancer
08/02/2005US6923939 Heat activated membrane introduction apparatus and method for screening materials
08/02/2005US6923902 Methods and apparatus for measuring NOx gas concentration, for detecting exhaust gas concentration and for calibrating and controlling gas sensor
08/02/2005US6923894 Biosensor with multiple sampling ways
08/02/2005US6923188 Method of sampling contaminants of semiconductor wafer carrier
08/02/2005US6923070 Unbonded system for strength testing of concrete cylinders
08/02/2005US6923040 Device and process for measuring breath alcohol
08/02/2005US6922851 large-capacity can having a wide mouth; a removable small-capacity cup containing a removable closable specimen container, the cup's rim dimensioned to sit in the mouth; and a removable cover for the can; for 24 hour kidney test; easier to use
08/02/2005CA2358993C Small volume in vitro analyte sensor and related methods
08/02/2005CA2290582C Rapid evaluation of the ratio of biological molecules
08/02/2005CA2161210C Process for measuring amount of endotoxin or (1 3)-.beta.-d-glucan by kinetic turbidimetric method
07/2005
07/30/2005CA2456593A1 Peptides for the diagnosis, monitoring and treatment of diabetes
07/28/2005WO2005069220A2 Method for mapping defects on leather
07/28/2005WO2005069187A2 Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation
07/28/2005WO2005069022A1 Method and apparatus for measuring electrical conductivity
07/28/2005WO2005069021A1 Permittivity monitor uses ultra wide band transmission
07/28/2005WO2005069014A1 Method and apparatus for testing cement slurries
07/28/2005WO2005069013A1 Modulation of thrombomodulin proteolysis
07/28/2005WO2005069012A2 Ligands for i7l as modulators of orthopox viruses and methods for discovery thereof
07/28/2005WO2005069011A1 Methods and means of screening for rhomboid activity
07/28/2005WO2005069010A1 Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 4 (mglur4)
07/28/2005WO2005069009A2 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN STEROID PROGESTIN RECEPTOR BETA (mSR-BETA)
07/28/2005WO2005069008A1 Method for examining the activity of ion channels
07/28/2005WO2005069007A1 Improvements in or relating to lateral flow assay devices
07/28/2005WO2005069006A1 Novel antibody mediated surface enhanced raman scattering (sers) immunoassay and multiplexing schemes
07/28/2005WO2005069005A1 Device and methods for processing samples and detecting analytes of low concentration
07/28/2005WO2005069004A2 Solid-supported membranes inside porous substrates and their use in biosensors
07/28/2005WO2005069003A1 Methods for predicting susceptibility to cardiovascular disease
07/28/2005WO2005069002A1 Rapid test for antibodies against hiv in urine
07/28/2005WO2005069001A1 Microwell array chip and its manufacturing method
07/28/2005WO2005069000A2 Methods of identifying cytotoxic effects in quiescent cells
07/28/2005WO2005068999A1 Diagnostics and therapeutics for diseases associated with human progestin receptor gamma (mpr-gamma)
07/28/2005WO2005068998A1 Diagnostics and therapeutics for diseases associated with human progestin receptor aplha (msr-alpha)
07/28/2005WO2005068996A2 Phased micro analyzer iv
07/28/2005WO2005068991A1 Electrochemical sensor
07/28/2005WO2005068985A2 Method and device for the optical monitoring of a running fiber strand
07/28/2005WO2005068982A1 Method and system for colorimetric determination of a chemical or physical property of a turbid medium
07/28/2005WO2005068980A1 Protein imprinted polymers with integrated emission sites
07/28/2005WO2005068974A1 Method and apparatus for testing fibres
07/28/2005WO2005068968A1 A pump for supplying a gas to a sensor and methods therefor
07/28/2005WO2005068967A1 A device for investigating biological test fluids, especially blood, urine or the like
07/28/2005WO2005068663A2 Methods of using peroxisome proliferator-activated receptor alpha target genes
07/28/2005WO2005068653A1 Method for detecting the risk of cardiovascular diseases such as acute myocardial infarction and coronary heart disease by analysing defensin
07/28/2005WO2005068647A2 Methods for detecting bacterial pathogens
07/28/2005WO2005068624A1 Method of screening remedy for rheumatoid arthritis
07/28/2005WO2005068623A1 Method of screening remedy for rheumatoid arthritis
07/28/2005WO2005068612A2 Human hepatic progenitor cells and methods of use thereof
07/28/2005WO2005068504A1 Inflammatory cytokine inhibitor
07/28/2005WO2005068501A1 Methods and compositions for modulating a steroid receptor
07/28/2005WO2005067971A1 Drug for preventing and treating arteriosclerosis
07/28/2005WO2005067957A2 Use of a dg147 protein product for preventing and treating metabolic disorders
07/28/2005WO2005067912A1 Method of intentionally, noninvasively, therapeutically modulating fat in a living mammal
07/28/2005WO2005067907A1 Reagent for lacrimation examination and method of lacrimation examination
07/28/2005WO2005067793A1 Plate for a measuring cell
07/28/2005WO2005067788A1 Determination of glucose sensitivity and a method to manipulate blood glucose concentration
07/28/2005WO2005067710A1 Non-human mammal model comprising heterologous nucleated cells-use for screening compounds
07/28/2005WO2005067692A2 Detection and quantification of analytes in solution using polymers
07/28/2005WO2005067667A2 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
07/28/2005WO2005067651A2 Surface plasmon resonance based nanoliter tear osmometer
07/28/2005WO2005067648A2 Multiplex spatial profiling of gene expression
07/28/2005WO2005067644A2 Conjugated small molecules
07/28/2005WO2005067640A2 Methods for enhanced detection & analysis of differentially expressed genes using gene chip microarrays
07/28/2005WO2005067633A2 Method and apparatus for presentation of noninvasive glucose concentration information
07/28/2005WO2005067569A2 Method and apparatus for detecting hydrocarbons with nmr logs in wells drilled with oil-based muds
07/28/2005WO2005067486A2 Quantitative protein assay using single affinity capture agent for identification and detection
07/28/2005WO2005067478A2 Recombinant icosahedral virus like particle production in pseudomonads
07/28/2005WO2005067477A2 Anti-human lymphotoxin alpha antibodies, compositions, methods and uses
07/28/2005WO2005067425A2 Bacterial biosensors
07/28/2005WO2005067405A2 Method for screening responsiveness to drugs effective in treatment or prevention of vitiligo and method for prognosis of vitiligo
07/28/2005WO2005054510A3 Predicting response and outcome of metastatic breast cancer anti-estrogen therapy
07/28/2005WO2005052582A3 Methods and apparatus for cell based microarray assays
07/28/2005WO2005047901A3 Compositions and methods for detection and isolation phosphorylated molecules
07/28/2005WO2005047896A3 Automatic analysis of cellular samples
07/28/2005WO2005047530A3 Method for assaying compounds that modulate the activity of protein tyrosine phosphatase receptor zeta (ptprzeta)
07/28/2005WO2005045424A3 Methods for comparing functional sites in proteins
07/28/2005WO2005044961A3 High throughput screening methods for lubricating oil compositions
07/28/2005WO2005037439B1 Method and a device for treating microparticles
07/28/2005WO2005033330A3 Fluorescent probes for use in protein kinase inhibitor binding assay
07/28/2005WO2005031341A3 Methods for predicting development of insulin resistance
07/28/2005WO2005018552A3 Heparin binding proteins: sensors for heparin detection
07/28/2005WO2005017163A3 Phenotypic knockout of cell-surface proteins
07/28/2005WO2005016279A3 Melks as modifiers of the rac pathway and methods of use
07/28/2005WO2005013682A3 Animal model for the analysis of tumor metastasis
07/28/2005WO2005012901A3 Method for measuring aromatase activity
07/28/2005WO2005004793A3 Compositions and methods for treating coagulation related disorders
07/28/2005WO2005003394A3 Bio-barcode based detection of target analytes
07/28/2005WO2005001421A3 Improved piezoimmunosensor
07/28/2005WO2004108895A3 Humanized antibodies that recognize beta amyloid peptide
07/28/2005WO2004093828A3 Reverse-turn mimetics and method relating thereto
07/28/2005WO2004085668A3 Self-contained assay device for rapid detection of biohazardous agents
07/28/2005WO2004083909A3 Fiber-optic apparatus and method for making simultaneous multiple parameter measurements
07/28/2005WO2004069189A3 Methods of assessment of drug metabolizing enzymes
07/28/2005WO2004043236A3 Diagnosis of sepsis or sirs using biomarker profiles
07/28/2005WO2004035806A3 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene
07/28/2005WO2004021248A3 Automated framework for the analysis of biological data
07/28/2005WO2004003820A3 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer
07/28/2005WO2004002296A3 Therapeutic methods for reducing fat deposition and treating associated conditions
1 ... 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 ... 3937